youtube_live
Q4 2026 earnings • in 3 days
See detailschevron_right
A:NYSE
Agilent Technologies Inc
$170.29
arrow_downward
-2.88%(-5.05) 1D
Nov 20, 2:31:43 PM GMT-5 · USD
search
All symbols
No data
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for A...
Open
$175.10
High
$175.13
Low
$169.68
Mkt. cap
48.01B
Avg. vol.
2.05M
Volume
865.10K
Dividend
0.62%
Quarterly dividend
$0.26
Ex-dividend date
Oct 6, 2026
P/E ratio
33.56
52-wk high
$182.99
52-wk low
$108.35
EPS
$5.07
Beta
1.24
Shares outstanding
281.93M
No. of employees
18K
Open
$175.10
High
$175.13
Low
$169.68
Mkt. cap
48.01B
Avg. vol.
2.05M
Volume
865.10K
Dividend
0.62%
Quarterly dividend
$0.26
Ex-dividend date
Oct 6, 2026
P/E ratio
33.56
52-wk high
$182.99
52-wk low
$108.35
EPS
$5.07
Beta
1.24
Shares outstanding
281.93M
No. of employees
18K
News stories
From web sources and news partners
Investing.com
·
28 minutes ago
Hewlett Packard Enterprise, Agilent, Zoom and more set to report earnings Friday
www.debelegger.nl
·
13 hours ago
Agilent Technologies (A) Stock Price, Chart & Analysis
News Corp
·
21 hours ago
Keysight Technologies Inc. stock outperforms competitors despite losses on the day
News Corp
·
21 hours ago
Agilent Technologies Inc. stock underperforms Thursday when compared to competitors
Profile
Agilent Technologies, Inc. is an American global company headquartered in Santa Clara, California, that provides instruments, software, services, and consumables for laboratories. Agilent was established in 1999 as a spin-off from Hewlett-Packard. The resulting initial public offering of Agilent stock was the largest in the history of Silicon Valley at the time.
From 1999 to 2014, the company produced optics, semiconductors, EDA software and test and measurement equipment for electronics; that division was spun off to form Keysight. Since then, the company has continued to expand into pharmaceutical, diagnostics & clinical, and academia & government markets. Wikipedia
About Agilent Technologies Inc
CEOPadraig McDonnell
Employees18.2K
Founded1999
HeadquartersSanta Clara, California, United States
SectorHealth Care
Industry-
Websiteagilent.com
Analyst ratings
Based on 15 analysts giving stock ratings to A in the past 3 months
Strong buy
Buy
12
Hold
3
Sell
0
12-month forecast
Based on 15 Wall Street analysts offering 12 month price targets for A in the last 3 months.
Highest
Current $170.29
$196.00 (+15.10%)
Average
$183.60 (+7.82%)
Lowest
$150.00 (-11.91%)
Analyst | Recommendation | Action | Price target | Projected | Date |
|---|---|---|---|---|---|
Justin Bowers Deutsche Bank | Buy | Initiated | $190.00 | +11.6% | 10/26/2026 |
Eve Burstein Bernstein | Buy | Reiterated | $180.00 | +5.7% | 10/19/2026 |
Doug Schenkel UBS | Hold | Maintained | $180.00 | +5.7% | 10/14/2026 |
Avantika Dhabaria Bank of America Securities | Buy | Maintained | $190.00 | +11.6% | 10/13/2026 |
Michael Ryskin Bank of America Securities | Buy | Maintained | $190.00 | +11.6% | 10/13/2026 |
Avantika Dhabaria Bank of America Securities | Buy | Maintained | $190.00 | +11.6% | 10/13/2026 |
Daniel Brennan TD Cowen | Buy | Reiterated | $196.00 | +15.1% | 10/13/2026 |
Kallum Titchmarsh Morgan Stanley | Buy | Reiterated | $190.00 | +11.6% | 10/13/2026 |
Luke Sergott Barclays | Buy | Maintained | $195.00 | +14.5% | 10/07/2026 |
Evie Koslosky Goldman Sachs | Buy | Maintained | $185.00 | +8.6% | 09/20/2026 |
John Dunigan Jefferies | Hold | Maintained | $181.00 | +6.3% | 09/17/2026 |
Blayne Curtis Jefferies | Hold | Maintained | $155.00 | -9% | 09/11/2026 |
Unknown Analyst UBS | Hold | Initiated | $165.00 | -3.1% | 09/08/2026 |
Tycho Peterson Jefferies | Hold | Maintained | $155.00 | -9% | 09/02/2026 |
Daniel Arias Stifel Nicolaus | Buy | Maintained | $180.00 | +5.7% | 08/30/2026 |
Evan Stampler Wells Fargo | Buy | Maintained | $180.00 | +5.7% | 08/28/2026 |
David Westenberg Piper Sandler | Hold | Reiterated | $150.00 | -11.9% | 08/27/2026 |
Vijay Kumar Evercore ISI | Buy | Maintained | $172.00 | +1% | 08/27/2026 |
Dan Leonard RBC Capital | Buy | Maintained | $185.00 | +8.6% | 08/26/2026 |
Casey Woodring J.P. Morgan | Buy | Maintained | $190.00 | +11.6% | 08/27/2026 |
Patrick B Donnelly Citi | Buy | Maintained | $190.00 | +11.6% | 08/27/2026 |
Sidharth Sahoo HSBC | Buy | Maintained | $165.00 | -3.1% | 06/03/2026 |
Michael Polark Wolfe Research | Hold | Initiated | $135.00 | -20.7% | 06/01/2026 |
Brandon Couillard Wells Fargo | Buy | Maintained | $160.00 | -6% | 05/28/2026 |
Catherine Ramsey Schulte Robert W. Baird | Buy | Maintained | $156.00 | -8.4% | 05/26/2026 |
Jack Meehan Nephron | Buy | Upgraded | $145.00 | -14.9% | 03/26/2026 |
Next call in 3 days
Mon, Nov 23, 10:30 PM
Fiscal period
Q4 2026
- Normalized EPS / Est. (USD)
- GAAP EPS / Est. (USD)
- / $1.73
Revenue / Est. (USD)
- / 1.99B
Fiscal Q4 2026 earnings call
youtube_liveWaiting for the earnings call
At a glance: upcoming earnings
Insights from the latest news and reports
Previous reportsAll values in USD
Loading Previous Earnings...
Income statement
Revenue
Net income
- Quarterly
- Annual
All values in USD | Oct 2025 | Jan 2026 | Apr 2026 | Jul 2026 |
|---|---|---|---|---|
Revenue | 1.86B | 1.80B | 1.84B | 1.88B |
Cost of goods sold | 893.00M | 847.00M | 842.00M | 835.00M |
Cost of revenue | 893.00M | 847.00M | 842.00M | 835.00M |
Research and development expenses | 117.00M | 117.00M | 126.00M | 113.00M |
Total research and development expenses | - | - | - | - |
Selling, general, and admin expenses | 382.00M | 423.00M | 432.00M | 450.00M |
Operating expense | 499.00M | 540.00M | 558.00M | 563.00M |
Total operating expenses | 1.39B | 1.39B | 1.40B | 1.40B |
Operating income | 469.00M | 411.00M | 435.00M | 480.00M |
Other non operating income | 45.00M | 3.00M | 9.00M | 3.00M |
EBT including unusual items | 442.00M | 364.00M | 408.00M | 444.00M |
EBT excluding unusual items | 492.00M | 404.00M | 429.00M | 469.00M |
Income tax expense | 8.00M | 59.00M | 69.00M | 82.00M |
Effective tax rate | 1.81% | 16.21% | 16.91% | 18.47% |
Other operating expenses | - | - | - | - |
Net income | 434.00M | 305.00M | 339.00M | 362.00M |
Net profit margin | 23.32% | 16.96% | 18.47% | 19.28% |
Earnings per share | 1.59 | 1.36 | 1.49 | 1.62 |
Interest and investment income | 17.00M | 15.00M | 13.00M | 15.00M |
Interest expense | -27.00M | -25.00M | -25.00M | -29.00M |
Net interest expenses | -10.00M | -10.00M | -12.00M | -14.00M |
Depreciation and amortization charges | - | - | - | - |
EBITDA | 540.00M | 478.00M | 502.00M | 546.00M |
Gain or loss from assets sale | - | - | - | - |
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider | Position | Type | Date | Shares | Amount |
|---|---|---|---|---|---|
Page 1
Upcoming events